The primary goal of a radiologic
examination is to provide useful information for disease management. Radiologic
stud-ies can provide a diagnosis or can give information about dis-ease extent
or response to treatment. In the present medical climate, it has also become
imperative that radiologic workups be performed efficiently and in a cost-effective
man-ner. This requirement presents a problem for clinicians trying to decide
which test to order in a given clinical situation.
The major strengths and
weaknesses of neuroradiologic examinations have been discussed earlier. The
following brief discussion concerns the appropriate ordering of examinations in
clinical situations. Several points should be emphasized. First, although a
recommended modality may clearly be superior to another in evaluating a
particular neurologic condition, the choice of examination is not always
obvious before the diagnosis is established. For example, in patients with
nonfocal headache, MR scans are more sensi-tive than CT scans for detecting
most intracranial abnormal-ities. However, if the headache is produced by
subarachnoid hemorrhage, CT would be a much better examination than MR imaging,
because subarachnoid hemorrhage is nearly in-visible on MR images. Choice of
examinations may also be limited by what is locally available. If MR imaging is
unavail-able, or if the MR scanner is of poor quality or the interpret-ing
radiologist is inadequately trained in MR image interpretation, then CT would
be an excellent examination for evaluating most neurologic disorders.
Next, it is important to realize
that the least expensive ex-amination is not always the best first choice, even
in this cost-conscious age. For example, most suspected skull fractures should
be evaluated with CT scanning and not with plain films, despite the significant
cost differential, because what is really important in management decisions is
not the fracture itself but the potential underlying brain injury. Some
neuro-logic diseases require multiple radiologic studies for accurate
evaluation. Complex partial seizures refractory to medical management frequently
require multiple examinations to lo-calize the seizure focus prior to temporal
lobectomy. Such a workup normally includes MR imaging and ictal/interictal
SPECT and/or PET scanning of the brain, as well as a cerebral arteriogram to
identify cerebral dominance.
Finally, certain examinations are
contraindicated in cer-tain patients, and an alternative test must suffice.
Patients with ferromagnetic cerebral aneurysm clips or pacemakers should not
undergo MR imaging. Patients with a strong his-tory of allergic reaction to
iodinated contrast media should not routinely undergo contrast-enhanced CT
scanning, un-less they are pretreated with anti-inflammatory agents (ie,
steroids). MR scanning is frequently unsuccessful in claustro-phobic or
uncooperative patients unless they are sedated.
Congenital anomalies of the brain are best evaluated by MR imaging. MR imaging is the best examination for demon-strating intracranial anatomy. It provides excellent discrimi-nation between gray matter and white matter, superb views of the posterior fossa and craniocervical junction, and, most importantly, the ability to view the brain in any plane. MR imaging has, for all practical purposes, completely replaced CT for this indication. The one exception is in evaluation of osseous structures including various craniofacial anom-alies and in suspected premature fusion of the cranial sutures.
CT is the preferred modality for
studying practically all acute head injuries. Examination times are short,
intracranial hem-orrhage is well demonstrated, and skull fractures are readily
apparent. Unstable patients can also be easily monitored. In-travenous
administration of contrast agents is unnecessary in the usual trauma setting.
CTA and occasionally MRA areutilized with increasing frequency to assess for
vascular in-jury associated with blunt or penetrating trauma. CTA is typ-ically
the first-line evaluation for dissection or laceration, particularly when a
displaced fracture crosses a vascular fora-men or in the case of penetrating
vessel injury. Occasionally, cerebral arteriography is performed to look for
carotid or vertebral artery injury, particularly when CTA or MRA are
inconclusive or when there is an anticipated endovascular treatment of the
injured vessel.
Although MR imaging is not
routinely performed in the acute trauma setting, it may sometimes be helpful in
patients with neurologic deficits unexplained by a head CT examina-tion. For
example, traumatic brainstem hemorrhages are often difficult to see on CT scans
but are usually quite obvi-ous on MR images. MR imaging is also useful in
demonstrat-ing tiny shear lesions within the brain in diffuse axonal injury and
in assessing the brain in remote head trauma.
The best examination to perform
in most cases of suspected acute intracranial hemorrhage is a head CT scan. CT
scans can be obtained quickly, allowing rapid initiation of treat-ment, and
they are very good at demonstrating all types of intracranial hemorrhage,
including subarachnoid blood. Be-cause most nontraumatic subarachnoid
hemorrhage (SAH) is secondary to a ruptured cerebral aneurysm, CTA is now
performed routinely following a conventional head CT demonstrating SAH. In most
cases, the CTA is adequate for aneurysm detection and characterization prior to
surgical or endovascular treatment. MR imaging takes much longer to perform in
a potentially unstable patient, and subarachnoid hemorrhage may be difficult to
see. However, MR imaging is more useful in the subacute or chronic setting,
especially be-cause it gives information about when a hemorrhagic event
occurred. This information might be useful in such settings as nonaccidental
head trauma (eg, child abuse). MR imaging is also very sensitive to petechial
hemorrhage that frequently accompanies a cerebral infarction and could
potentially help to identify an underlying cause for an intracranial
hemor-rhage (eg, tumor, arteriovenous malformation, occluded dural sinus).
Cerebral arteriography is generally reserved when the etiology of hemorrhage is
not discernable by CTA/MRA, when it is necessary to evaluate the flow dynamics
of a vascular lesion or for planning endovascular treatment.
Although cerebral arteriography
has traditionally been con-sidered the “gold standard” for cerebral aneurysm
evaluation, CTA has supplanted catheter arteriography as the first-line imaging
modality for aneurysm detection. The current liter-ature varies slightly;
however, CTA is reported to have excel-lent sensitivity (greater than 95% for
aneurysms measuring4 mm or larger) as well as high specificity. In most cases,
CTA is adequate for surgical or endovascular treatment planning. If CTA fails
to identify a suspected aneurysm following SAH, cerebral arteriography will
typically be performed. Cerebral arteriography not only allows aneurysm
identification, but also provides other critical preoperative information such
as aneurysm orientation, presence of vasospasm, location of adjacent vessels,
and collateral intracranial circulation. Ar-teriography also helps to determine
which aneurysm has bled when more than one aneurysm is present. As men-tioned
previously, interventional neuroradiologists can treat aneurysms, usually in
nonsurgical patients, by placing thrombosing material (ie, coils) within the
aneurysm itself via an endovascular approach.
Although most patients with
symptomatic cerebral aneurysms present with subarachnoid hemorrhage, some
aneurysms act like intracranial masses. These situations usu-ally warrant evaluation
by MR imaging as a first examination. The same is sometimes true with posterior
communicating ar-tery aneurysms (which can produce symptoms related to the
adjacent third cranial nerve) or with aneurysms arising from the internal
carotid artery as it courses through the cavernous sinus (which can affect any
of the cranial nerves that lie within this structure, including cranial nerves
III, IV, V, or VI).
Patients with a vascular
malformation (eg, arteriovenous malformation, cavernous angioma, venous
angioma, or cap-illary telangiectasia) often seek medical attention after an
in-tracranial hemorrhage or a seizure. In this setting, the first test that
should be performed is either a CT examination (to look for intracranial hemorrhage)
or MR imaging. Although an intracranial hemorrhage is usually very obvious on a
CT scan, the vascular malformation itself may be difficult, if not impossible,
to see unless intravenous contrast material is ad-ministered. MR imaging, on
the other hand, is quite sensitive for detecting vascular malformations,
whether they have bled or not. The choice of the initial examination for
evaluation of a vascular malformation can be difficult. Usually, patients
undergo noncontrast head CT scanning to look for intracra-nial hemorrhage when
they come to the emergency depart-ment. This is usually followed by CTA,
particularly if an arteriovenous malformation (AVM) is suspected. Otherwise,
the head CT is followed by gadolinium-enhanced MR imag-ing to further characterize
the CT findings. If a true high-flow arteriovenous malformation is suspected,
either clinically or from a cross-sectional imaging study, then cerebral
arteriog-raphy is performed. In contrast to cerebral aneurysms, catheter
angiography is still performed routinely to evaluate AVMs. This is done because
catheter angiography provides details of flow dynamics within the AVM and
demonstrates certain anatomic features that are necessary to elucidate prior to
initiation of treatment. As spatial resolution and dynamicsequences improve, CT
or MR angiography may someday re-place conventional arteriography in the workup
of these le-sions, as with aneurysms.
Today, most patients with
suspected cerebral infarction un-dergo CT scanning in the acute setting, even
though infarc-tions are demonstrated earlier and are more obvious on MR
imaging. So why is CT usually performed first? The answer is that clinicians
who manage stroke patients are not so inter-ested in seeing the infarct itself.
Infarct location is usually sus-pected from the physical examination, and acute
infarcts may not even be visible on CT scans for 12 to 24 hours after onset of
stroke symptoms. Clinicians are very interested, though, to know if a stroke is
secondary to something besides an infarct (eg, intracranial hemorrhage, brain
tumor), or if an infarct is hemorrhagic, because thrombolytic agents would be
con-traindicated in this setting. CT can quickly answer both of these
questions. MR imaging, specifically diffusion-weighted imaging, can sensitively
detect acute infarctions and is typically ordered in cases of high clinical
suspicion, when the initial CT study is nondiagnostic or when brainstem or
posterior fossa infarcts are suspected.
The underlying cause of most
cerebral infarctions is thromboembolism related to atherosclerosis. A CT/CTA or
MR/MRA (including DW and PW MR imaging) study may provide a positive imaging
diagnosis of brain infarction, re-veal the extent and location of vessel
occlusion, demonstrate the volume and severity of ischemic tissue, and predict
final infarct size and clinical prognosis. CT and MR perfusion can identify
areas of completed infarct (ie, infarct core) and po-tentially salvageable
surrounding brain parenchyma at risk of infarction (ie, ischemic penumbra).
Ultrasonography and cerebral arteriography can also be performed in the setting
of stroke or transient ischemic attack to identify vascular stenoses or
occlusions; these examinations are usually re-served for patients who might be
candidates for carotid en-darterectomy. Functional examinations (SPECT and PET)
have also been used in patients with strokelike symptoms to identify regions of
the brain at risk for infarction. These stud-ies are not widely available and
therefore do not enter into the imaging algorithm for most stroke patients.
In most medical centers, MR
imaging is performed to as-sess brain tumor response to treatment. Anatomic
imaging is often supplemented with some type of physiologic imaging including
MR perfusion, MR spectroscopy, and PET scan-ning. Perfusion MRI, MRS, and PET
scanning can frequently differentiate recurrent tumor from postradiation tissue
necrosis, which can mimic tumor on an MR or a CT scan. MR perfusion imaging
also provides functional information regarding the vascular density (ie,
neovascularity) of a tumor, which may help to predict tumor grade or help guide
a potential biopsy site.
Today, cerebral arteriography is
rarely performed for brain tumor evaluation except to map the blood supply of
very vascular tumors (ie, juvenile angiofibromas, paragan-gliomas)
preoperatively. Such lesions can also be embolized prior to surgery in order to
minimize intraoperative blood loss by injecting various materials into feeding
vessels to occlude them.
Intracranial infections are best
evaluated by contrast-en-hanced MR imaging. Abscesses, cerebritis, subdural
empye-mas, and other infectious or inflammatory processes are all very well
demonstrated. MR imaging is especially useful in as-sessing patients with
acquired immunodeficiency syndrome (AIDS). Not only does it allow
identification of secondary in-fections (eg, toxoplasmosis, cryptococcosis,
progressive multi-focal leukoencephalopathy), but it is also exquisitely
sensitive to the white matter changes produced by the human immun-odeficiency
virus itself. CT scanning is less sensitive than MR imaging in the detection of
intracranial infections and should be reserved for patients in whom MR imaging
is con-traindicated. Cerebral arteriography is only useful in one par-ticular
situation, suspected vasculitis. Involvement of brain arteries and arterioles
in this condition requires arteriogra-phy for diagnostic confirmation.
The best examination to order in
the setting of suspected brain tumor is a contrast-enhanced MR scan. This is
true for primary neoplasms as well as for metastatic disease. MR im-aging is
especially useful in identifying tumors of the pitu-itary region, brainstem,
and posterior fossa, including the cerebellopontine angle.
Although MR imaging is the
preferred examination for in-tracranial neoplasms, it is occasionally
supplemented by a CT scan, which can give important pretreatment information
not provided by MR images. For example, CT can demonstrate tumor calcification,
occasionally a useful factor in differenti-ating between types of neoplasms.
Also, CT is very useful in identifying bone destruction in skull-base lesions.
In most medical centers, MR
imaging is performed to as-sess brain tumor response to treatment. Anatomic
imaging is often supplemented with some type of physiologic imaging including
MR perfusion, MR spectroscopy, and PET scan-ning. Perfusion MRI, MRS, and PET
scanning can frequently differentiate recurrent tumor from postradiation tissue
necrosis, which can mimic tumor on an MR or a CT scan. MR perfusion imaging
also provides functional information regarding the vascular density (ie,
neovascularity) of a tumor, which may help to predict tumor grade or help guide
a potential biopsy site.
Today, cerebral arteriography is
rarely performed for brain tumor evaluation except to map the blood supply of
very vascular tumors (ie, juvenile angiofibromas, paragan-gliomas)
preoperatively. Such lesions can also be embolized prior to surgery in order to
minimize intraoperative blood loss by injecting various materials into feeding
vessels to occlude them.
Intracranial infections are best
evaluated by contrast-en-hanced MR imaging. Abscesses, cerebritis, subdural
empye-mas, and other infectious or inflammatory processes are all very well
demonstrated. MR imaging is especially useful in as-sessing patients with
acquired immunodeficiency syndrome (AIDS). Not only does it allow
identification of secondary in-fections (eg, toxoplasmosis, cryptococcosis,
progressive multi-focal leukoencephalopathy), but it is also exquisitely
sensitive to the white matter changes produced by the human immun-odeficiency
virus itself. CT scanning is less sensitive than MR imaging in the detection of
intracranial infections and should be reserved for patients in whom MR imaging
is con-traindicated. Cerebral arteriography is only useful in one par-ticular
situation, suspected vasculitis. Involvement of brain arteries and arterioles
in this condition requires arteriogra-phy for diagnostic confirmation.
As with suspected intracranial
infections, this large and di-verse group of diseases is best evaluated with MR
imaging, which sensitively detects white matter abnormalities. In fact, one of
the very first clear indications for MR imaging was in the workup of suspected
multiple sclerosis. Although brain abnormalities in these conditions may be
quite obvious on MR imaging, there is one problem: many of these conditions
appear very similar, and an exact diagnosis may not be possible.
In patients with dementia and
suspected neurodegenerative disease, PET imaging is currently the procedure of
choice for diagnostic evaluation.
Seizure is a common clinical
indication for imaging the brain, particularly in the emergency setting. CT is
the best modality to screen for multiple underlying causes of seizure including
hemorrhage, mass lesion, or vascular malforma-tion. CT is also very useful to
assess for secondary trauma that may occur during a seizure. MRI is often
subsequently performed depending on various factors including the pa-tient’s
age, clinical presentation, and type of seizure, or in the case of epilepsy.
MRI is superior to CT in evaluating fine cerebral anatomy because of its
excellent soft-tissue contrast and the absence of beam hardening artifact, as
well as its mul-tiplanar capability. Particular MR protocols are utilized to
discriminate the hippocampal structures and to detect other epileptogenic foci,
including various cortical malformations, neoplasms, and vascular
malformations.
In the case of medically
refractory epilepsy, patients may pursue surgery for more definitive treatment.
During surgi-cal planning, additional functional imaging performed in-cludes
ictal SPECT and interictal PET. These studies help confirm a suspected
epileptogenic focus, which demon-strates increased activity during or
immediately following a seizure (SPECT) versus decreased metabolic activity
be-tween seizures (PET). Cerebral arteriography is often per-formed prior to
epilepsy surgery in order to establish cerebral dominance by intracarotid
sodium amytal injection (Wada test). Following catheter injection of amytal
into the internal carotid artery, function within the corresponding cerebral
hemisphere is temporarily depressed, allowing for neurological testing of
memory and language in the con-tralateral hemisphere.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.